Overview
Highly Commended, BMA Medical Book Awards 2013 Oncology research and practice in lung cancer continues to develop rapidly. This latest edition of an acclaimed reference briefs the oncology community with a review of the recent literature, emphasizing the most significant therapeutic advances. The expert contributions of Lung Cancer Therapy Annual 7 offer an update of the impact that this information will have on the day-to-day management of the lung cancer patient. New to the seventh edition are four new chapters on the treatment of non-small cell lung cancer (NSCLC) and a new chapter on thymoma. Additional topics include: Oncogenic driver mutations First line therapy of advanced non-small cell lung cancer without activating EGFR mutation Second line therapy of non-small cell lung cancer Adjunct and neoadjunct therapy of non-small cell lung cancer Advances in surgery of lung cancer; advances in radiotherapy of lung cancer Mesothelioma Thymic tumors
Full Product Details
Author: Rolf A. Stahel (Clinic of Oncology, University Hospital Zurich, Zurich)
Publisher: Taylor & Francis Ltd
Imprint: CRC Press
Edition: 7th edition
Weight: 0.570kg
ISBN: 9781841848655
ISBN 10: 1841848654
Pages: 184
Publication Date: 13 August 2012
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Hardback
Publisher's Status: Active
Availability: In Print
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.
Reviews
This is an excellent resource for beginners as well as advanced specialists in the field. The references are current to the year 2008 and the individual chapters are brief and complete and will give readers a solid foundation in the treatment of lung cancer to build upon. - K. P. Ravikrishnan, FRCP (C), FACP FCCP(William Beaumont Hospitals)
""This is an excellent resource for beginners as well as advanced specialists in the field. The references are current to the year 2008 and the individual chapters are brief and complete and will give readers a solid foundation in the treatment of lung cancer to build upon."" -K. P. Ravikrishnan, FRCP (C), FACP FCCP(William Beaumont Hospitals) K. P. Ravikrishnan, FRCP (C), FACP FCCP(William Beaumont Hospitals) **Description** This annual compendium of articles pertaining to the treatment of lung cancer with pertinent references is well written and will help busy practitioners learn about advances in treatment. It is an excellent resource for trainees in oncology and fellows, as well as nurses, nurse clinicians, and nurse navigators. The book is current and the references are date to 2008. **Purpose** The purpose is to review the recent literature on the developments in therapeutic methods for lung cancer and to summarize the currently available modalities for treating small cell and non-small cell lung cancer. **Audience** The book will be useful to healthcare professionals in the field of oncology, including physicians and paramedical personnel. It can be used as well by the residents and students in training and those in affiliated areas, such as pharmacology. With its well written style and simple format, it is suitable for generalists as well. **Features** The introductory chapter is a very good outline of the worldwide problems in healthcare, especially the care of lung cancer patients. The impact of lung cancer on healthcare, with a strong emphasis on the impact of smoking cessation on the decrease in cancer incidence among male smokers is well addressed. The recent developments in the pharmacogenetics of non-small cell lung cancer are covered well; this section is useful for a beginner to get a good grasp of the topic and is thorough enough for an advanced reader to brush up on the topic. The chapters on the treatment of lung cancer are the highlights of the book and are excellent resources to build on to expand your knowledge on these topics. **Assessment** This is an excellent resource for beginners as well as advanced specialists in the field. The references are current to the year 2008 and the individual chapters are brief and complete and will give readers a solid foundation in the treatment of lung cancer to build upon.
Author Information
Rolf A. Stahel, M.D. is head of the Center for Lung and Thoracic Oncology and Senior Staff Physician at the Clinic of Oncology, University Hospital of Zurich as well as Titular Professor of Medicine at the University of Zurich, Switzerland. He is certified in Internal Medicine and Medical Oncology by both the American and Swiss Board. His major interest is thoracic oncology, including multidisciplinary treatment approaches, translational research and targeted therapy.
